More problems for Slater & Gordon Limited as shares suspended from trade

Slater & Gordon Limited (ASX:SGH) looks in trouble.

| More on:
a woman

You鈥檙e reading a free article with opinions that may differ from The Motley Fool鈥檚 Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Troubled law firm Slater & Gordon Limited (ASX: SGH) suspended its own shares from trade this morning in a move that will make investors increasingly nervous ahead of its half-year results announcement expected on February 29.

Back in March of 2015 Slater & Gordon announced the “transformational” $1.3 billion acquisition of the claims management business of UK company Quindell Plc.

Management weren’t聽wrong in聽describing the deal as “transformational”, with Slater & Gordon聽losing around聽90% of its聽value from top to bottom over the course of 2015 as the company went聽from market darling to dunce聽on the back of a string of disastrous developments after the acquisition.

Foremost is the problem that the聽Quindell deal now looks a monumental blunder, with聽Slater & Gordon today announcing to expect impairments to the goodwill value of the UK business.

To make matters worse is the fact that the Conservative UK government now intends to wind back much of the ability of legal services operators to claim for fast track road traffic accidents in an attack on what it considers to be the over-the-top ‘no win / no fee’ compensation culture in the UK. Low level fast track road聽traffic accidents are one of Quindell’s claims management businesses core areas of operation and the proposed reforms could not have come at a worse possible time for Slater & Gordon.

Analysts are likely to be working through lunch when the company does reveal its half-year results on February 29, with much attention focused on cash flows, accounting adjustments, and Slater & Gordon’s perilous debt position post-Quindell acquisition. Expect volatility when the law firm聽returns to the ASX boards.

Motley Fool contributor Tom Richardson owns shares of Slater & Gordon Limited. You can find Tom on Twitter @tommyr345 Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on 鈴革笍 Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
鈴革笍 Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
鈴革笍 Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more

asx investor daydreaming about US shares
鈴革笍 How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more

person reading news on mobile phone
鈴革笍 Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more